FASN-IN-3
FASN-IN-3 is a fatty acid synthase (FASN) inhibitor extracted from patent US20170119786A1, compound 242A[1].
Product Specifications
CAS Number
[2097262-60-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Fatty Acid Synthase (FASN)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Heterocyclic_modulators_1.html
Purity
98.06
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
N#CC1=CC=C(C2CN(C(C3=CC(C4=C(C)C(C)=NN4)=C(C)C=C3C)=O)C2)C=C1
Molecular Formula
C24H24N4O
Molecular Weight
384.47
Precautions
H302, H315, H319, H335
References & Citations
[1]Buckley, Douglas I, et al. HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS. US20170119786A1
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
251133-ML750 100 µL
RING1 (Ring Finger Protein 1, Ring1A, RNF1) (MaxLight 750) discontinued
Sign In for Pricing
View Details 
MBS1106393-01 0.02 mg (E-Coli)
Recombinant Brucella suis biovar 1 Aspartate carbamoyltransferase (pyrB)
Sign In for Pricing
View Details MBS1106393-02 0.02 mg (Yeast)
Recombinant Brucella suis biovar 1 Aspartate carbamoyltransferase (pyrB)
Sign In for Pricing
View Details